ReviewImmune Dysfunction and Infections in Patients With Cirrhosis
Section snippets
State of Immune Dysfunction in Cirrhosis
Cirrhosis-associated immune dysfunction syndrome (CAIDS) is a multifactorial state of systemic immune dysfunction (Figure 1), which decreases their ability to clear cytokines, bacteria, and endotoxins from circulation. The liver contains 90% of the reticuloendothelial (RE) cells,7 such as Kupffer and sinusoidal endothelial cells, that are central to clearing bacteria. When radiolabeled E. coli and P. aeruginosa were injected intravenously, 70% and 96% of their populations, respectively, were
Bacterial Translocation
Bacterial translocation is the migration of bacteria or bacterial products from the intestinal lumen to mesenteric lymph nodes (Figure 2).24 Bacterial translocation is known to be increased in cirrhosis and has been pathogenetically linked to the development of SBP.5, 6 It has also been implicated as a cause of recurrent SBP.25 Patients with cirrhosis have slowed intestinal motility, which leads to intestinal bacterial overgrowth.26 This overgrowth, along with portosystemic shunting, enables
SIRS, Sepsis, and Cirrhosis
Systemic inflammatory response syndrome (SIRS) is not uncommon in cirrhosis, and sepsis is defined as SIRS in the presence of confirmed bacterial infection (Figure 3).1, 2, 11, 27, 28, 29, 30 Bacterial derived toxins, such as peptidoglycans from gram-positive bacteria or lipopolysaccharides from gram-negative bacteria, bind to Toll-like receptors which initiate a cascade of cell signaling. Toll-like receptors trigger either nuclear factor μB or mitogen activated protein kinase, which in turn
Gastrointestinal Bleeding–Associated Infections and Prophylaxis
GI bleeding is associated with an increased incidence of infection, and approximately 17% to 45% of cases lead to an episode of SBP or bacteremia.46 Conversely, the presence of infection has been found to increase the risk of early bleeding.47, 48 Goulis et al49 hypothesize that bacterial endotoxins stimulate hepatic stellate cell contraction and endothelial NO production, which then increase sinusoidal pressure and inhibit platelet aggregation, respectively.
Patients who present with acute
Urinary Tract Infection
UTI occurs in approximately 15% to 20% of hospitalized patients with cirrhosis; it is twice as frequent in patients with cirrhosis compared with matched controls.3, 99 Women have a 4 times higher rate of bacteriuria than men.99 Gram-negative bacilli, such as E. coli and Klebsiella spp., are the primary causative agents. Notably, bacteriuria is not associated with an increased risk of sepsis, SBP, or other infections often seen in patients with cirrhosis.99 Although more frequent among those
Summary
Patients with cirrhosis are in a multifactorial immunocompromised state which predisposes them to a higher risk of infection. Bacterial infections, particularly SBP and bacteremia, are an important cause of morbidity and mortality in these patients. Gram-negative enteric bacteria appear to be the most common causative organisms. However, other unusual bacteria and fungi are also frequently observed and more virulent in patients with cirrhosis relative to those without liver disease. Moreover,
Acknowledgments
The authors appreciate the in-depth review and comments of Dr Jasmohan Bajaj from Virginia Commonwealth University.
References (146)
- et al.
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis
Hepatology
(2002) - et al.
Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study
Dig Liver Dis
(2001) - et al.
Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis
J Hepatol
(1994) - et al.
Gut microflora in the pathogenesis of the complications of cirrhosis
Best Pract Res Clin Gastroenterol
(2004) - et al.
Prevention and treatment of infections in patients with cirrhosis
Best Pract Res Clin Gastroenterol
(2007) - et al.
Liver bacterial clearance following hepatic artery ligation and portocaval shunt
J Surg Res
(1991) - et al.
Patients with acute on chronic liver failure display “sepsis-like” immune paralysis
J Hepatol
(2005) - et al.
Deficient phospholipase C activity in blood polimorphonuclear neutrophils from patients with liver cirrhosis
J Hepatol
(2004) - et al.
Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis
Gastroenterology
(1993) - et al.
Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-alpha and lipopolysaccharide in patients' blood
J Infect Chemother
(2004)
HCV-related autoimmune and neoplastic disorders: the HCV syndrome
Dig Liver Dis
Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score
Gastroenterology
The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome
J Hepatol
Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients
Gastroenterology
Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study
Gastroenterology
Bacterial infection in the pathogenesis of variceal bleeding
Lancet
A prospective study of bacterial infections in patients with cirrhosis
J Hepatol
Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage
Gastroenterology
Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study
Nutrition
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus documentInternational Ascites Club
J Hepatol
Spontaneous bacterial peritonitis--in-hospital mortality, predictors of survival, and health care costs from 1988 to 1998
Am J Gastroenterol
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis
Gastroenterology
Optimization of ascitic fluid culture technique
Gastroenterology
A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method
J Hepatol
Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management
J Hepatol
Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation
J Hepatol
Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis
Gastroenterology
Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study
Hepatology
Cefotaxime twice daily versus ceftriaxone once dailyA randomized controlled study in patients with serious infections
Diagn Microbiol Infect Dis
Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis
J Hepatol
Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial
Hepatology
Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: results of short- and long-term administration, with daily and weekly dosages
J Hepatol
Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis
Clin Gastroenterol Hepatol
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis
Gastroenterology
Prevalence and risk factors of bacteriuria in cirrhotic patients: a prospective case-control multicenter study in 244 patients
J Hepatol
Bacteriuria in patients with cirrhosis
J Hepatol
Bacterial infections, sepsis, and multiorgan failure in cirrhosis
Semin Liver Dis
Infections in patients with cirrhosis increase mortality 4-fold and should be used in determining prognosis
Gastroenterology
In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease
J Infect Dis
Bacterial infection-related morbidity and mortality in cirrhosis
Am J Gastroenterol
Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome
Gut
Ammonia impairs neutrophil phagocytic function in liver disease
Hepatology
In vitro study of neutrophil apoptosis in liver cirrhosis
Intern Med
Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils
J Exp Med
Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis
Hepatology
Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis
N Engl J Med
Drinking pattern and socio-cultural aspects on immune response: an overview
Proc Nutr Soc
Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake
Alcohol Clin Exp Res
Bacterial translocation (BT) in cirrhosis
Hepatology
Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis
Hepatology
Cited by (286)
Clinical characteristics and antimicrobial susceptibility of non-vaccine serotype Streptococcus pneumoniae in adult Japanese patients with pneumonia
2024, Journal of Infection and ChemotherapyBacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients
2024, Digestive and Liver DiseaseRevisiting the association between vitamin D deficiency and active tuberculosis: A prospective case-control study in Taiwan
2024, Journal of Microbiology, Immunology and Infection
Conflicts of interest The authors disclose no conflicts.